Branded Generics: A Gateway to Emerging Markets
Around the globe, emerging markets are on the move. From Brazil, Russia and India to China, Turkey, Mexico and South Korea, experts predict emerging markets will represent 70 percent of industry growth rates by 2013.
While some leading companies have already established their foothold in those regions with the standard approach of offering low-volume innovative drugs to the emerging middle class, others are taking a far more inventive approach—branded generics.
A hybrid of generic and brand name products, branded generics not only allow companies to use existing distribution systems and established marketing techniques to sell premium-priced generics, they offer consumers the reassurance of a trusted name amidst rising fears of unsafe counterfeits.
What’s more, it makes sense. Along with a dense population constantly searching for a better standard of living, increased lifestyle-related disease and new healthcare reforms in developing nations, emerging markets offer untapped potential.
In Branded Generics--A Gateway to Emerging Markets , FirstWord delves into the potential of branded generics, and the progress key companies are already experiencing. The report, which explores the strategies being employed, from acquiring generic companies to marketing licensed products, examines the opportunities, drawbacks and potential hurdles of this inventive approach. Offering an overview of the generics market in emerging economies, the report includes an outline of opportunities, case studies and a prescription for how to succeed. Concisely written and backed by solid statistics, charts and diagrams, FirstWord's latest report offers a fast-track into what has become a critical new market.
The report offers insights into
The report
While some leading companies have already established their foothold in those regions with the standard approach of offering low-volume innovative drugs to the emerging middle class, others are taking a far more inventive approach—branded generics.
A hybrid of generic and brand name products, branded generics not only allow companies to use existing distribution systems and established marketing techniques to sell premium-priced generics, they offer consumers the reassurance of a trusted name amidst rising fears of unsafe counterfeits.
What’s more, it makes sense. Along with a dense population constantly searching for a better standard of living, increased lifestyle-related disease and new healthcare reforms in developing nations, emerging markets offer untapped potential.
In Branded Generics--A Gateway to Emerging Markets , FirstWord delves into the potential of branded generics, and the progress key companies are already experiencing. The report, which explores the strategies being employed, from acquiring generic companies to marketing licensed products, examines the opportunities, drawbacks and potential hurdles of this inventive approach. Offering an overview of the generics market in emerging economies, the report includes an outline of opportunities, case studies and a prescription for how to succeed. Concisely written and backed by solid statistics, charts and diagrams, FirstWord's latest report offers a fast-track into what has become a critical new market.
The report offers insights into
- How major pharma companies are using innovative strategies to engage a new market
- Which critical issues face new players
The report
- Examines the current state of generics in emerging markets
- Reviews which companies are making inroads and how
- Includes statistics, charts and market analysis for Asia, Central and Eastern Europe and Latin America
- Reviews strategies used for entry, pricing and branding
- Provides an overview on the hurdles and opportunities for those entering the market
EXECUTIVE SUMMARY
EMERGING MARKETS
Factors aiding industry growth in emerging markets
Not realizing full potential
OVERVIEW OF THE GLOBAL GENERICS MARKET
Generic Market Growth factors
Generics Market Statistics
Big Pharma Enters the Generics Market
Branded Generics
Branded Generics in Emerging Markets
Strategies for Branded Generics in Emerging Markets
Big Pharma Enters the Generics Market
CENTRAL AND EASTERN EUROPE
Opportunities for Generics
Main Players in the Generics Market
Branded Generics
Case Study: Polish Generics Market
Factors Aiding Success in CEE Markets
EMERGING MARKETS OF ASIA
China
Generics in China
International Presence in the Chinese Market
Opportunities
How to succeed
India
Opportunities in the Indian Market
The Indian Market for Generics
Physician Perception of Branded Generics
Keys for success
LATIN AMERICA
Generic Drugs in Latin America
Case Study: Brazil
How to succeed in Latin America
CONCLUSION
INDEX
EMERGING MARKETS
Factors aiding industry growth in emerging markets
Not realizing full potential
OVERVIEW OF THE GLOBAL GENERICS MARKET
Generic Market Growth factors
Generics Market Statistics
Big Pharma Enters the Generics Market
Branded Generics
Branded Generics in Emerging Markets
Strategies for Branded Generics in Emerging Markets
Big Pharma Enters the Generics Market
CENTRAL AND EASTERN EUROPE
Opportunities for Generics
Main Players in the Generics Market
Branded Generics
Case Study: Polish Generics Market
Factors Aiding Success in CEE Markets
EMERGING MARKETS OF ASIA
China
Generics in China
International Presence in the Chinese Market
Opportunities
How to succeed
India
Opportunities in the Indian Market
The Indian Market for Generics
Physician Perception of Branded Generics
Keys for success
LATIN AMERICA
Generic Drugs in Latin America
Case Study: Brazil
How to succeed in Latin America
CONCLUSION
INDEX
